Droz JP - Search Results

1

High-dose chemotherapy in germ-cell tumors.

Droz JP, Culine S, Biron P, Kramar A. Droz JP, et al. Ann Oncol. 1996 Dec;7(10):997-1003. doi: 10.1093/oxfordjournals.annonc.a010523. Ann Oncol. 1996. PMID: 9037356 Free article. Review.

2

Acute tumor lysis syndrome in poor-risk germ cell tumors: does it exist?

Kattan J, Culine S, Tavakoli-Razavi T, Kramar A, Droz JP. Kattan J, et al. Among authors: droz jp. Support Care Cancer. 1994 Mar;2(2):128-31. doi: 10.1007/BF00572095. Support Care Cancer. 1994. PMID: 7512416

3

[Experience with non-Hodgkin's lymphoma].

Biron P, Droz JP. Biron P, et al. Among authors: droz jp. Bull Cancer. 1995;82 Suppl 1:53s-55s. Bull Cancer. 1995. PMID: 7626855 French.

4

High failure rate of carboplatin-etoposide combination in good risk non-seminomatous germ cell tumours.

Kattan J, Mahjoubi M, Droz JP, Kramar A, Culine S, Boutan-Laroze A, Chazard M. Kattan J, et al. Among authors: droz jp. Eur J Cancer. 1993;29A(11):1504-9. doi: 10.1016/0959-8049(93)90283-l. Eur J Cancer. 1993. PMID: 8217352 Clinical Trial.

5

Prognostic factors in non-seminomatous germ cell tumours of the testis. Experience at the Institut Gustave-Roussy.

Kramar A, Droz JP, Rey A, Bouzy J, Philippot I, Culine S. Kramar A, et al. Among authors: droz jp. Eur Urol. 1993;23(1):188-95. doi: 10.1159/000474592. Eur Urol. 1993. PMID: 8386648 Review.

6

Early intensified chemotherapy with autologous bone marrow transplantation in first line treatment of poor risk non-seminomatous germ cell tumours. Preliminary results of a French randomized trial.

Chevreau C, Droz JP, Pico JL, Biron P, Kerbrat P, Cure H, Héron JF, Chevallier B, Fargeot P, Kramar A, et al. Chevreau C, et al. Among authors: droz jp. Eur Urol. 1993;23(1):213-7; discussion 218. doi: 10.1159/000474596. Eur Urol. 1993. PMID: 8386652 Clinical Trial.

7

Prediction of long-term response after high-dose chemotherapy with autologous bone marrow transplantation in the salvage treatment of non-seminomatous germ cell tumours.

Droz JP, Kramar A, Pico JL. Droz JP, et al. Eur J Cancer. 1993;29A(6):818-21. doi: 10.1016/s0959-8049(05)80416-2. Eur J Cancer. 1993. PMID: 8387318

8

Is there a role for second-look laparotomy in the management of malignant germ cell tumors of the ovary? Experience at Institut Gustave Roussy.

Culine S, Lhomme C, Michel G, Leclere J, Duvillard P, Droz JP. Culine S, et al. Among authors: droz jp. J Surg Oncol. 1996 May;62(1):40-5. doi: 10.1002/(SICI)1096-9098(199605)62:1<40::AID-JSO9>3.0.CO;2-R. J Surg Oncol. 1996. PMID: 8618400

9

Primary chemotherapy in patients with nonseminomatous germ cell tumors of the testis and biological disease only after orchiectomy.

Culine S, Theodore C, Terrier-Lacombe MJ, Droz JP. Culine S, et al. Among authors: droz jp. J Urol. 1996 Apr;155(4):1296-8. J Urol. 1996. PMID: 8632558 Clinical Trial.

10

Cisplatin-based chemotherapy after retroperitoneal lymph node dissection in patients with pathological stage II nonseminomatous germ cell tumors.

Culine S, Theodore C, Farhat F, Bekradda M, Terrier-Lacombe MJ, Droz JP. Culine S, et al. Among authors: droz jp. J Surg Oncol. 1996 Mar;61(3):195-8. doi: 10.1002/(SICI)1096-9098(199603)61:3<195::AID-JSO6>3.0.CO;2-6. J Surg Oncol. 1996. PMID: 8637206

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

470 results

Search Page

Filters